Study of RA drugs: Anti-TNF vs non-TNF drugs
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial looks at how two types of rheumatoid arthritis (RA) medications affect patients. It aims to compare anti-TNF drugs with other RA drugs to see if one type is better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have rheumatoid arthritis diagnosed by a doctor using the 2010 ACR guidelines.
- You should be between 18 and 65 years old.
- You must be able to read and write.
- You need to have been taking either an anti-TNF or another RA drug for 1 to 3 years.
- You cannot be pregnant, have cancer, or serious heart conditions.
- You should be able to do physical activities like cycling and not have a regular exercise habit (3 or more days per week).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different drugs used to treat rheumatoid arthritis in Saudi Arabia. If you have rheumatoid arthritis and have been treated for at least a year, this study may help doctors learn which medicines work best.
This study tests an investigational drug called TLL-018 for people with moderate to severe rheumatoid arthritis who have not improved enough with standard disease-modifying drugs. It aims to see if the drug can reduce joint pain and swelling.
This trial tests a medical device to help people with rheumatoid arthritis stay in remission while on biologic therapy. The goal is to see if the device can prevent flares and maintain disease control.
This trial tests taking a JAK inhibitor (a type of pill that helps calm inflammation in rheumatoid arthritis) by mouth. It aims to see how well it works and if it's safe for people with RA who need this kind of medicine.
This trial studies an add-on treatment approach for rheumatoid arthritis (RA) in adults whose symptoms did not improve with standard “first-line” medicines. It may help people who still have active RA after trying certain disease-modifying drugs.
This Phase 3 study compares two ways to treat active rheumatoid arthritis: a TNF-blocking biologic versus a targeted pill treatment. It may help people who are not doing well on (or cannot tolerate) certain biologic therapies to find a better, more practical option.
Hear when a new Rheumatoid Arthritis (RA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.